Piper Jaffray downgraded Endologix (NASDAQ: ELGX) from Overweight to Neutral with a price target of $4.75 (from $7.00).Analyst Matt O''Brien ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE